SUPERNUS PHARMACEUTICALS, INC.
Develops and commercializes therapies for CNS diseases like epilepsy, migraine, and ADHD.
SUPN | US
Overview
Corporate Details
- ISIN(s):
- US8684591089
- LEI:
- Country:
- United States of America
- Address:
- 9715 KEY WEST AVENUE, 20850 ROCKVILLE
- Website:
- https://www.supernus.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. With over 30 years of experience, the company develops novel therapies to provide benefits for patients. Its commercial portfolio includes treatments for conditions such as epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), and dyskinesia in Parkinson's disease patients. Supernus maintains a pipeline of product candidates and is dedicated to research and development to address unmet medical needs within the CNS therapeutic area.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SUPERNUS PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SUPERNUS PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SUPERNUS PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
